Description

3-[(3As,4S,7As)-7A-Methyl-1,5-Dioxooctahydro-1H-Inden-4-Yl]Propionic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex, stereochemically defined decalin-fused structure. This compound is critical for B2B buyers requiring a reliable and consistent building block for the synthesis of complex, biologically active molecules. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutic agents, particularly in areas requiring sophisticated chiral chemistry.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of novel active pharmaceutical ingredients (APIs), particularly for steroidal or terpenoid-based therapeutics.
• Organic Synthesis Building Block: Used in complex multi-step syntheses, including cyclization and functionalization reactions, to construct intricate molecular architectures.
• Asymmetric Catalysis Research: Serves as a valuable substrate or ligand precursor in the development and study of new asymmetric catalytic processes.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies and lead optimization campaigns for drug discovery programs targeting various disease pathways.
• Reference Standard: Used as an analytical standard for quality control and method development in pharmaceutical manufacturing and regulatory compliance testing.

Basic Information

Product Name	3-[(3As,4S,7As)-7A-Methyl-1,5-Dioxooctahydro-1H-Inden-4-Yl]Propionic Acid
CAS No.	1944-63-4
Molecular Formula	C13H18O4
Molecular Weight	238.28 g/mol
Synonyms	(3aS,4S,7aR)-7a-Methyl-1,5-dioxooctahydro-1H-indene-4-propanoic Acid; 4-(2-Carboxyethyl)-7a-methyl-1,5-dioxo-octahydroindene; 7a-Methyl-1,5-dioxooctahydro-1H-indene-4-propionic Acid; (4S,7aS)-7a-Methyl-1,5-dioxooctahydro-1H-inden-4-ylpropionic Acid; NSC 51143; 1944-63-4; Decahydronaphthalenepropionic acid derivative
EINECS	Contact for details

Quality Control

Our 3-[(3As,4S,7As)-7A-Methyl-1,5-Dioxooctahydro-1H-Inden-4-Yl]Propionic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including chiral purity verification, to ensure it meets the exacting standards required for pharmaceutical R&D and production. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to ensure full traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from strong oxidizing agents and bases. For long-term storage under inert atmosphere, please contact our technical team for specific recommendations.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.